A systematized approach to the management of the depressed and anxious patient

International Journal of Psychiatry in Clinical Practice

Volumn 2, Issue 1, 1998, Pages 27-30

  Zajecka, John M ^a   Ross, Jeffrey S ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Antidepressant discontinuation syndrome; Comorbidity; Mixed anxiety depression; Polypharmacy; Subsyndromal

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; CLOMIPRAMINE; DESIPRAMINE; IMIPRAMINE; LITHIUM; MIRTAZAPINE; NEFAZODONE;

ANXIETY NEUROSIS; COMORBIDITY; DEPRESSION; DOSE RESPONSE; DRUG EFFICACY; HUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; REMISSION; REVIEW; TRANQUILIZING ACTIVITY; TREATMENT PLANNING;

EID: 0031971285     PISSN: 13651501     EISSN: None     Source Type: Journal    
DOI: 10.3109/13651509809115110     Document Type: Review

References (24)

1. Wetzler S, Katz MM (1989) Problems with the differentiation of anxiety and depression. J Psychiatr Res 23: 1-12.
2. Alnaes R, Torgensen S (1990) DSM-III personality disorders among patients with major depression, anxiety disorders, and mixed conditions. J Nerv Ment Dis 178: 693-8.
3. Liebowitz MR, Hollander E, Schneier F et al (1990) Anxiety and depression: discrete diagnostic entities? J Clin Psychopharmacol 10 (suppl 3): 61S-66S.
4. Katon W, Roy-Byrne PP (1991) Mixed anxiety and depression. J Abnorm Psychol 100: 337-45.
5. Clayton PJ (1990) The comorbidity factor: establishing the primary diagnosis in patients with mixed symptoms of anxiety and depression. J Clin Psychiatry 51 (suppl): 35-39.
6. Stein MB, Shea CA, Uhde TW (1989) Social phobic symptoms in patients with panic disorder: practical and theoretical implications. Am J Psychiatry 146: 235-8.
7. Rudd MD, Dahm PF, Rajab MH (1993) Diagnostic comorbidity in persons with suicidal ideation and behavior. Am J Psychiatry 150: 928-34.
8. Wittchen H-U, Essau CA, Krieg J-C (1991) Anxiety disorders: similarities and differences of comorbidity in treated and untreated groups. Br J Psychiatry 159 (suppl): 23-33.
9. Clayton PJ (1987) Anxious depression: a reemerging subtype of depression. In: Anxious depression: assessment and treatment (ed G Racagni, E Smeraldi) 1-6. Raven Press, New York.
10. Zajecka JM, Tracy KA, Mitchell S (1997) Discontinuation symptoms after treatment with serotonin reuptake inhibitors: a literature review. J Clin Psychiatry 58: 291-7.
11. Fawcett J, Marcus RN, Anton G et al (1995) Response of anxiety and agitation symptoms during nefazodone treatment of major depression. J Clin Psychiatry 56 (suppl 6): 37-42.
12. Zajecka JM (1996) The effect of nefazodone on comorbid anxiety symptoms associated with depression: experience in family practice and psychiatric outpatients settings. J Clin Psychiatry 57 (suppl 2): 10-14.
13. Ballenger JC (1986) Pharmacotherapy of the panic disorders. J Clin Psychiatry 47 (suppl): 27-32.
14. DeVeaugh-Geiss J, Landaw P, Katz R (1989) Treatment of obsessive-compulsive disorder with clomipramine. Psychiatr Ann 19: 97-101.
15. Liebowitz MR, Campeas R, Levin A et al (1987) Pharmacotherapy of social phobia: a condition distinct from panic attacks. Psychosomatics 28: 305-8.
16. Liebowitz MR, Quitkin FM, Steward JW et al (1984) Phenelzine vs. imipramine in atypical depression. Arch Gen Psychiatry 41: 669-77.
17. Schneier FR, Liebowitz MR, Davies SO et al (1990) Fluoxetine in panic disorder. J Clin Psychophannacol 10: 119-21.
18. Primeau F, Fontaine R, Beauclair L (1990) Valproic acid and panic disorder. Can J Psychiatry 35: 248-50.
19. Zajecka J, Fanelli J, Ross J et al (1994) Valproic acid in the treatment of panic disorder (Poster). New Clinical Drug Evaluation Unit meeting organised by the Division of Clinical and Treatment Research, National Institute of Mental Health, Marco Island, Fl.
20. Barlow DH (1988) Anxiety and its disorders. In: The nature and treatment of anxiety and panic (ed DH Barlow) 425-7. Guilford Press, New York.
21. Van der Kolk BA, Dreyfuss D, Michaels M (1994) Fluoxetine in post-traumatic stress disorder. J Clin Psychiatry 55: 517-22.
22. Davidson JRT (1992) Drug therapy of post-traumatic stress disorder. Br J Psychiatry 160: 309-14.
23. Goodman WK, McDougle CJ, Price LH (1992) Pharmacotherapy of obsessive compulsive disorder. J Clin Psychiatry 53 (suppl): 29-37.
24. Zetin M, Kramer MA (1992) Obsessive-compulsive disorder. Hosp Community Psychiatry 43: 689-99.